NCT02016859Unknown不适用
Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients
Dr. Yishai Ofran1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2014年1月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Time to recovery from sepsis or time to death
研究概览
简要总结
Immature Platelet Fraction (IPF) is a new value in CBC blood tests Recent Studies showed that this value may be another prognostic factor in critically ill patients such as those admitted to ICU, or those with neutropenic Fever.
The purpose of the study is to check if the IPF may be used as a prognostic Factor in these patients
详细描述
In this study we have 3 groups of patients
- Patients admitted to ICU
- Patients admitted with neutropenic fever
- Patients admitted with hip fractures it is a prospective study, not interventional, we'll take blood samples of these patients including CBC count eith IPF and other inflammation markers such as CRP and we'll compare CRP to IPF in addition to clinical follow-up of the patient till discharge.
At the end of this study we'll compare the efficacy of IPF as a prognostic Factor in these patients
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Admission to hospital blood sample is taken between 24:00 pm till 15:00 pm
排除标准
- •blood sample is taken after 15:00 pm in the first day of admission during the week
- •blood sample is taken on weekend: thursday 15:00 pm till saturday 24:00 pm
结局指标
主要结局
Time to recovery from sepsis or time to death
时间窗: 6 months
the primary outcome is the result of the patient's admission on which data analysis will be based
次要结局
- Predicting value of IPF for prognosis(baeline 6 months)
研究者
Dr. Yishai Ofran
Doctor
Rambam Health Care Campus
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP SyndromePre-Eclampsia, SevereHELLP SyndromeMicroangiopathyNCT03232359AYMAN ABDELKADER MOHAMED ABDELKADER57
Unknown
不适用
Prospective Screening Programme for Malignant TumorsHematologic TestsMalignant TumorNCT04230200Sun Yat-sen University10,000
招募中
不适用
The Neonatal Hemorrhagic Risk Assessment in ThrombocytopeniaNeonatal ThrombocytopeniaBleedingNCT04598750Karolinska Institutet250
终止
不适用
Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer ResectionVenous ThromboembolismNCT01608919University of Colorado, Denver4
Unknown
不适用
RP% Measurement by FCM as a Diagnostic Test for ITPImmune ThrombocytopeniaNCT02967328Shandong University500